Differential Regulation and Predictive Potential of MacroH2A1 Isoforms in Colon Cancer

Por Sporn, Judith C., Jung, Barbara
Publicado em 2012

BARD1 expression predicts outcome in colon cancer

Por Sporn, Judith C., Hothorn, Torsten, Jung, Barbara
Publicado em 2011

Effects of Activin and TGFβ on p21 in Colon Cancer

Por Bauer, Jessica, Sporn, Judith C., Cabral, Jennifer, Gomez, Jessica, Jung, Barbara
Publicado em 2012

Loss of histone variant macroH2A2 expression associates with progression of anal neoplasm

Por Hu, Wan-Hsiang, Miyai, Katsumi, Sporn, Judith C, Luo, Linda, Wang, Jean Y J, Cosman, Bard, Ramamoorthy, Sonia
Publicado no J Clin Pathol (2016)

Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer

Por Ozden, Ozkan, Bishehsari, Faraz, Bauer, Jessica, Park, Seong-Hoon, Jana, Arundhati, Baik, Seung Hyun, Sporn, Judith C., Staudacher, Jonas J., Yazici, Cemal, Krett, Nancy, Jung, Barbara
Publicado no Sci Rep (2016)

Activin Signaling in Microsatellite Stable Colon Cancers Is Disrupted by a Combination of Genetic and Epigenetic Mechanisms

Por Jung, Barbara, Gomez, Jessica, Chau, Eddy, Cabral, Jennifer, Lee, Jeffrey K., Anselm, Aimee, Slowik, Przemyslaw, Ream-Robinson, Deena, Messer, Karen, Sporn, Judith, Shin, Sung K., Boland, C. Richard, Goel, Ajay, Carethers, John M.
Publicado em 2009

MacroH2A histone variants limit chromatin plasticity through two distinct mechanisms

Por Kozlowski, Marek, Corujo, David, Hothorn, Michael, Guberovic, Iva, Mandemaker, Imke K, Blessing, Charlotte, Sporn, Judith, Gutierrez‐Triana, Arturo, Smith, Rebecca, Portmann, Thomas, Treier, Mathias, Scheffzek, Klaus, Huet, Sebastien, Timinszky, Gyula, Buschbeck, Marcus, Ladurner, Andreas G
Publicado no EMBO Rep (2018)